Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.00
Bid: 60.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.333%)
Open: 61.00
High: 61.00
Low: 61.00
Prev. Close: 61.00
MYX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restricted Common Shares to be Traded in CREST

28 Aug 2015 07:00

RNS Number : 3439X
MyCelx Technologies Corporation
28 August 2015
 

28 August 2015

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

Restricted Common Shares to be traded in CREST

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, announces that, in accordance with Regulation (EU) No. 909/2014 of the European Parliament and of the Council of 23 July 2014 on improving securities settlement in the European Union and on central depositories (the "EU Regulation") which requires all shares traded on AIM to be capable of electronic settlement, as of 1 September 2015 the existing restricted line of common shares which trades under the ticker symbol MYXR with ISIN number USU624551078 will be eligible for settlement in CREST as Depository Interests (the "Restricted DI Line").

Holders of restricted Common Shares will be able to deposit their restricted Common Shares into CREST in exchange for Depository Interests and trade such Depository Interests in uncertificated form on AIM (the "Transfer Programme"). Restricted Common Shares which participate in the Transfer Programme will continue to be subject to the restrictions on transfer. The Restricted DI Line will continue to use the ticker symbol MYXR and ISIN number USU624551078.

Holders of restricted Common Shares who do not participate in the Transfer Programme will continue to hold their Common Shares in certificated form, which will retain their legend and the restrictions on transfer. Consequently, trading in certificated restricted Common Shares may continue to take place. However, such holders of certificated restricted Common Shares should note that certificated stock is not capable of electronic settlement in accordance with the EU Regulation and will need to be dematerialised prior to electronic settlement. No Common Shares will be deposited into CREST without the positive action of the relevant shareholder.

In general, under US securities law, Common Shares that have been in issue for more than one year and are not held by an 'affiliate' of the Company qualify for characterisation as unrestricted Common Shares ("Unrestricted Common Shares"). An affiliate for this purpose is a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Company or a director or officer of the Company. All Unrestricted Common Shares are eligible for migration to, and trading on, the Company's unrestricted MYX line with the ISIN number US62847T2024.

There has been no change in the Company's issued share capital. The Company will continue to have a total of 18,770,117 Common Shares admitted to trading on AIM (excluding those Common Shares admitted and not allotted under the blocklisting announced on 25 February 2011). The Company holds no Common Shares in treasury.

The Company will be writing to shareholders affected shortly to inform them of the process of moving their shares to the Restricted DI Line. 

For further information please contact:

 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Mark Clark, CFO

 

Tel: +1 888 306 6843

RFC Ambrian Limited

Corporate Finance

Samantha Harrison

Alexander Millar

 

Corporate Broking

Jonathan Williams

Kim Eckhof

 

Tel: +44 20 3440 6800

Numis Securities Limited

Corporate Broking

James Black

Ben Stoop

 

Tel: +44 20 7260 1000

Bell Pottinger

Nick Lambert

Henry Lerwill

 

Tel: +44 20 3772 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFISTRIDFIE
Date   Source Headline
17th May 20167:00 amRNSFinal Results
16th Mar 20167:00 amRNSAppointment of CFO/Grant of Share Options
4th Mar 20161:25 pmRNSHolding(s) in Company
4th Mar 20167:00 amRNSTrading Update
11th Jan 20165:30 pmRNSHolding(s) in Company
29th Dec 20152:23 pmRNSHolding(s) in Company
18th Dec 201510:13 amRNSHolding(s) in Company
15th Dec 20155:25 pmRNSHolding(s) in Company
15th Dec 20155:24 pmRNSHolding(s) in Company
11th Dec 20157:00 amRNSTrading Update
3rd Dec 201511:33 amRNSBlocklisting Interim Review
1st Oct 20157:00 amRNSProgress Update on Trials
10th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSRestricted Common Shares to be Traded in CREST
20th Aug 20157:00 amRNSDirector Resignation
17th Aug 20157:00 amRNSProgress Report on Trials and Cost Reduction
29th Jul 20152:01 pmRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Statement
1st Jul 20157:00 amRNSChange of Adviser
5th Jun 20157:00 amRNSDirector/PDMR Shareholding
28th May 20159:48 amRNSBlocklisting Interim Review
21st May 20153:01 pmRNSDirector/PDMR Shareholding
19th May 20154:01 pmRNSResult of Annual Meeting
19th May 20157:00 amRNSAnnual Meeting Statement
17th Apr 20157:00 amRNSMailing of 2014 Annual Report & Notice of AGM
20th Mar 20157:00 amRNS2014 Preliminary Results
15th Jan 20155:39 pmRNSTrading Update
5th Jan 20157:00 amRNSClose of US Placing
2nd Jan 201512:00 pmRNSHolding(s) in Company
22nd Dec 201412:54 pmRNSHolding(s) in Company
10th Dec 20147:00 amRNSEquity Placing
2nd Dec 20147:00 amRNSEquity Placing
27th Nov 20143:58 pmRNSBlocklisting Interim Review
19th Nov 20147:00 amRNSTrading Statement
12th Sep 20147:00 amRNSHalf Year Results Statement
26th Aug 20147:00 amRNSMiddle East Contract Win
7th Jul 20147:00 amRNSHalf Year Trading Update & Contract Wins
13th May 20143:31 pmRNSResult of Annual Meeting
29th Apr 20144:44 pmRNSBlocklisting Interim Review
22nd Apr 201410:02 amRNSAnnual Report & Accounts Posted
20th Mar 20147:00 amRNS2013 Preliminary Results
30th Jan 20147:00 amRNSYear End Trading Update & Contract Wins
10th Dec 20133:29 pmRNSTotal Voting Rights
4th Dec 20133:24 pmRNSHolding(s) in Company
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.